Quoin Pharmaceuticals Ltd ADR (QNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,623 | 3,117 | 2,845 | 1,834 | 2,401 |
| Marketable Securities | 10,434 | 7,190 | 9,726 | 12,857 | 8,294 |
| TOTAL | $14,926 | $10,497 | $13,221 | $15,265 | $11,286 |
| Non-Current Assets | |||||
| Intangibles | 483 | 508 | 533 | 558 | 583 |
| Other Non-Current Assets | 300 | 383 | 300 | 300 | 300 |
| TOTAL | $783 | $892 | $833 | $858 | $883 |
| Total Assets | $15,709 | $11,389 | $14,055 | $16,123 | $12,169 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,506 | 823 | 1,420 | 959 | 1,127 |
| Accrued Expenses | 2,675 | 2,651 | 2,533 | 3,265 | 2,455 |
| TOTAL | $4,181 | $3,474 | $3,953 | $4,224 | $3,582 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,324 | 2,474 | 2,624 | 2,774 | 2,924 |
| TOTAL | $2,324 | $2,474 | $2,624 | $2,774 | $2,924 |
| Total Liabilities | $6,505 | $5,948 | $6,576 | $6,998 | $6,505 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 589 | 144 | 114 | 114 | 105 |
| Retained earnings | -55,166 | -52,855 | -50,505 | -48,531 | -46,203 |
| TOTAL | $9,205 | $5,442 | $7,478 | $9,126 | $5,664 |
| Total Liabilities And Equity | $15,709 | $11,389 | $14,055 | $16,123 | $12,169 |